The first stop for professional medicines advice

Biosimilars

25 results

Applied filters

Preparing to use tocilizumab biosimilar

5 March 2024Introducing biosimilar tocilizumab needs planning. Work with the multidisciplinary team to ensure familiarity with the area and develop an implementation plan.

Good governance when implementing eculizumab biosimilar

6 March 2024Governance should consider processes for approval, procurement and supply, prescribing and administration, monitoring, and pharmacovigilance.

Biosimilar and key generic medicines - delivering better value

11 December 2024An overview of NHS England and NHS SPS roles in implementing biosimilar and key generic medicines and what to expect in 2025/26.

Biosimilars

Regularly updated material to support the introduction of eculizumab, natalizumab, ranibizumab, tocilizumab and ustekinumab biosimilars.
Registration required

Summary of biopharmaceutical stability data reviewed and available extended shelf-life data

4 June 2021The stability of several aseptically compounded ready to administer presentations of monoclonal antibody products and other biopharmaceuticals is presented.
admin